Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

Ítems similars

• Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy
  per: Alexandra Langlois, et al.
  Publicat: (2020-04-01)
• Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy
  per: Langlois, Alexandra, et al.
  Publicat: (2020)
• Sensitivity and specificity of double-blinded penicillin skin testing in relation to oral provocation with amoxicillin in children
  per: Labrosse, Roxane, et al.
  Publicat: (2020)
• Comparison of ImmunoCAP and Immulite serum specific IgE assays for the assessment of egg allergy
  per: Graham, François, et al.
  Publicat: (2016)
• Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
  per: Barrios, Jonathan Lacombe, et al.
  Publicat: (2011)